Stereotactic radiosurgery best for cancer patients with 4+ brain metastases

Reuters Health - 28/10/2020 - For cancer patients with four or more brain metastases, stereotactic radiosurgery (SRS) reduces cognitive decline compared with whole-brain radiation therapy (WBRT), without compromising overall survival, according to results of a randomized controlled trial. "This study provides strong evidence to support replacing whole-brain radiation with more focal radiation for patients with multiple brain metastases," lead author Dr. Jing Li, co-director of the Brain Metastasis Clinic at The University of Texas MD Anderson Cancer Center in Houston, said in a news release. Up to 30% of cancer patients develop brain metastases and the incidence is rising due to prolonged survival and better imaging surveillance, Dr. Li noted in a press briefing October 26 at the American Society for Radiation Oncology (ASTRO) virtual annual meeting, where the findings were presented. "In patients with one to three brain metastases, SRS has replaced WBRT as t...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on 28 October, 20206 November, 2020